Many patients using tirzepatide achieve higher percentages of total body weight reduction, especially at higher maintenance doses
"Research chemical" peptides from unregulated sources carry additional risks unknown purity, incorrect concentrations, contamination
The ICER improved (reduced) from SEK213,502 per QALY in the base case to SEK173,563 per QALY for oral semaglutide versus empagliflozin (payer perspective) (Table 3)
This study included 12 week-old Wistar albino male rats that were bred in-house at the animal facility at the Department of Pharmacology, School of Medicine in Zagreb, Croatia
The reported E-value of 3.31 suggests that an unmeasured confounder would need relatively strong associations with both semaglutide use and COVID-19-related mortality to fully explain the finding, but it does not eliminate that possibility